Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (2 active)

Company-led only

1 records in Main database

Compare	Program	Company	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications	Inspect
Add	Strekin STR001 for Sudden Sensorineural Hearing Loss	Strekin AG	Therapeutic	-	Small Molecule	Phase 3	Completed	Details checkedClinical trial listing onlyHistorical/discontinued	registry · Priority 2	82%	AdultSudden / SSNHL+2	Hearing LossSudden Sensorineural Hearing Loss+1

Strekin AG · Small Molecule · Phase 3

CompletedTherapeutic

Evidence

registry

Confidence

82%

Indications

Hearing LossSudden Sensorineural Hearing LossSensorineural Hearing Loss

Population

AdultSudden / SSNHLAcuteSensorineural